Know These 3 Facts to Avoid Paying Half Your Retirement Income to the IRS - December 19, 2019Zacks Investment Research • 12/19/19
Here's Why Bristol-Myers Squibb (BMY) is a Great Momentum Stock to BuyZacks Investment Research • 12/17/19
Bristol-Myers Placed A Big Bet On Celgene’s Pipeline. Will It Pay Off For Investors?The Motley Fool • 12/16/19
bluebird bio's Advancement With Zynteglo Gene Therapy Is Properly Set Up For Commercial SuccessSeeking Alpha • 12/16/19
Biotech Stocks Burn A Hole In Big Pharma's Pocket. Look For More In 2020Investors Business Daily • 12/13/19
Why Bristol-Myers Squibb Could Be the Best Large-Cap Pharmaceutical Stock for 202024/7 Wall Street • 12/13/19
3 Reasons Why Growth Investors Shouldn't Overlook Bristol-Myers (BMY)Zacks Investment Research • 12/05/19
Bristol-Myers Has Now Acquired Celgene — So, Should You Buy BMY Stock?Investors Business Daily • 12/04/19